Xynomic Pharmaceuticals Holdings, Inc.
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Vaccines
Other Names/Subsidiaries
- Bison Capital Acquisition Corp
Latest on Xynomic Pharmaceuticals Holdings, Inc.
Xynomic Pharmaceuticals Inc. has sealed its second in-licensing deal with Germany's Boehringer Ingelheim GMBH by acquiring exclusive, worldwide rights to develop, manufacture and commercialize BI 8
During the final quarter of 2017, biopharma start-up fundraising showed a 17% decline from the previous quarter, a total of $2.62bn compared to $3.17bn in the third quarter. It was a continuing downwa
IN VITRO DIAGNOSTICS Alliances Oxford Immunotec Global PLC Qiagen NV Oxford Immunotec Global PLC and Qiagen NV have settled patent infringement litigation surrounding Qiagen's QuantiFERON-TB
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in